• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53在结直肠癌中的临床病理相关性及预后意义

p53 in colorectal cancer: clinicopathological correlation and prognostic significance.

作者信息

Scott N, Sagar P, Stewart J, Blair G E, Dixon M F, Quirke P

机构信息

Department of Pathology, University of Leeds, UK.

出版信息

Br J Cancer. 1991 Feb;63(2):317-9. doi: 10.1038/bjc.1991.74.

DOI:10.1038/bjc.1991.74
PMID:1997114
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1971769/
Abstract

p53 protein was detected by immunohistochemistry in 42% of 52 colorectal adenocarcinomas. Positive tumours were significantly more frequent in the distal colon, and demonstrated a higher rate of cell proliferation. No correlation was found with tumour grade, Dukes' stage, presence of DNA aneuploidy or patient survival. The role of p53 in colorectal carcinogenesis is discussed with particular reference to differences between proximal and distal large bowel cancers.

摘要

采用免疫组织化学方法在52例结肠腺癌中检测到42%存在p53蛋白。阳性肿瘤在结肠远端更为常见,且细胞增殖率更高。未发现与肿瘤分级、Dukes分期、DNA非整倍体的存在或患者生存率相关。特别参照近端和远端大肠癌之间的差异,讨论了p53在结直肠癌发生中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78fd/1971769/2f152515bde6/brjcancer00210-0153-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78fd/1971769/2f152515bde6/brjcancer00210-0153-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78fd/1971769/2f152515bde6/brjcancer00210-0153-a.jpg

相似文献

1
p53 in colorectal cancer: clinicopathological correlation and prognostic significance.p53在结直肠癌中的临床病理相关性及预后意义
Br J Cancer. 1991 Feb;63(2):317-9. doi: 10.1038/bjc.1991.74.
2
Evaluation of four antibodies in detecting p53 protein for predicting clinicopathological and prognostic significance in colorectal adenocarcinoma.评估四种抗体检测p53蛋白对预测结直肠癌临床病理及预后意义的作用。
Clin Cancer Res. 1999 Dec;5(12):4126-32.
3
Clinico-pathological correlation and prognostic significance of nuclear p53 protein in colorectal cancer. Colorectal Cancer Study Group of the University and Health Care District of Modena.结直肠癌中核p53蛋白的临床病理相关性及预后意义。摩德纳大学及医疗保健区结直肠癌研究组
Ital J Gastroenterol. 1996 May;28(4):205-10.
4
Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance.结直肠癌中p53和Bcl-2的免疫组织化学检测:无预后意义的证据
Br J Cancer. 1998 Jun;77(11):1842-7. doi: 10.1038/bjc.1998.306.
5
Prognostic significance of p53 expression in relation to DNA ploidy in colorectal adenocarcinoma.p53表达在结直肠癌中与DNA倍体的关系及其预后意义
Virchows Arch A Pathol Anat Histopathol. 1993;423(6):443-8. doi: 10.1007/BF01606533.
6
Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma.细胞质p53癌蛋白在结直肠癌中的预后意义。
Lancet. 1992 Dec 5;340(8832):1369-73. doi: 10.1016/0140-6736(92)92558-w.
7
Increased p53 protein content of colorectal tumours correlates with poor survival.结直肠癌肿瘤中p53蛋白含量增加与生存率低相关。
Br J Cancer. 1992 Oct;66(4):758-64. doi: 10.1038/bjc.1992.352.
8
[P53 protein in adenocarcinoma of the large intestine].[P53蛋白在大肠腺癌中的表达]
Wiad Lek. 1997;50 Suppl 1 Pt 1:87-91.
9
Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance.bcl-2在Dukes B期和C期结直肠癌患者中的免疫组化表达:在评估预后意义方面与p53和ki-67的相关性
Pol J Pathol. 2005;56(4):179-85.
10
Correlation of p53 with the clinicopathologic features and prognosis of colorectal adenocarcinoma.p53与结直肠癌临床病理特征及预后的相关性
Surg Today. 1994;24(1):85-7. doi: 10.1007/BF01676893.

引用本文的文献

1
Management of Colorectal Cancer Using Nanocarriers-based Drug Delivery for Herbal Bioactives: Current and Emerging Approaches.基于纳米载体的药物输送系统用于中草药生物活性成分的结直肠癌治疗管理:当前和新兴方法。
Curr Pharm Biotechnol. 2024;25(5):599-622. doi: 10.2174/0113892010242028231002075512.
2
Distinct Driver Pathway Enrichments and a High Prevalence of Mutations in Right Colon Cancer in Chile: A Preliminary Comparative Analysis.智利右半结肠癌中独特的驱动途径富集和高突变率:一项初步的比较分析。
Int J Mol Sci. 2024 Apr 25;25(9):4695. doi: 10.3390/ijms25094695.
3
The expanding regulatory universe of p53 in gastrointestinal cancer.

本文引用的文献

1
Trends in right and left-sided colon cancer.左右侧结肠癌的趋势。
Dis Colon Rectum. 1983 Jun;26(6):393-8. doi: 10.1007/BF02553382.
2
The cellular protein p53 in human tumours.人类肿瘤中的细胞蛋白p53。
Mol Biol Med. 1984 Aug;2(4):261-72.
3
Different age and sex relationship for cancer of subsites of the large bowel.大肠癌不同亚部位癌症的年龄和性别关系各异。
p53在胃肠道癌中不断扩展的调控范围
F1000Res. 2016 Apr 26;5:756. doi: 10.12688/f1000research.8363.1. eCollection 2016.
4
Inducible Nitric Oxide Synthase in the Carcinogenesis of Gastrointestinal Cancers.诱导型一氧化氮合酶在胃肠道癌症发生中的作用
Antioxid Redox Signal. 2017 Jun 20;26(18):1059-1077. doi: 10.1089/ars.2016.6850. Epub 2016 Oct 31.
5
Determination of Tumor Heterogeneity in Colorectal Cancers Using Heterogeneity Tissue Microarrays.使用异质性组织微阵列测定结直肠癌中的肿瘤异质性
Pathol Oncol Res. 2015 Sep;21(4):1183-9. doi: 10.1007/s12253-015-9953-4. Epub 2015 May 31.
6
Loss of Heterozygosities in Five Tumor Suppressor Genes (FHIT Gene, p16, pRb, E-Cadherin and p53) in Thyroid Tumors.甲状腺肿瘤中五个肿瘤抑制基因(脆性组氨酸三联体基因、p16、pRb、E-钙黏蛋白和 p53)杂合性缺失。
Clin Exp Otorhinolaryngol. 2014 Mar;7(1):53-8. doi: 10.3342/ceo.2014.7.1.53. Epub 2014 Feb 5.
7
Inhibition of autophagy and tumor growth in colon cancer by miR-502.miR-502 抑制结肠癌中的自噬和肿瘤生长。
Oncogene. 2013 Mar 21;32(12):1570-9. doi: 10.1038/onc.2012.167. Epub 2012 May 14.
8
Implications of microRNAs in colorectal cancer development, diagnosis, prognosis, and therapeutics.微小RNA在结直肠癌发生、诊断、预后及治疗中的意义
Front Genet. 2011 Nov 3;2(78). doi: 10.3389/fgene.2011.00078.
9
Development and progression of colorectal neoplasia.结直肠肿瘤的发展和演进。
Cancer Biomark. 2010;9(1-6):235-65. doi: 10.3233/CBM-2011-0160.
10
Pharmacological inhibition of Mdm2 triggers growth arrest and promotes DNA breakage in mouse colon tumors and human colon cancer cells.药物抑制 Mdm2 会引发小鼠结肠肿瘤和人结肠癌细胞的生长停滞,并促进 DNA 断裂。
Mol Carcinog. 2012 May;51(5):363-78. doi: 10.1002/mc.20795. Epub 2011 May 6.
Br J Cancer. 1984 Dec;50(6):825-9. doi: 10.1038/bjc.1984.262.
4
Growth regulation of a cellular tumour antigen, p53, in nontransformed cells.非转化细胞中细胞肿瘤抗原p53的生长调节
Nature. 1984;308(5955):199-201. doi: 10.1038/308199a0.
5
Role of the p53 protein in cell proliferation as studied by microinjection of monoclonal antibodies.通过显微注射单克隆抗体研究p53蛋白在细胞增殖中的作用。
Mol Cell Biol. 1984 Feb;4(2):276-81. doi: 10.1128/mcb.4.2.276-281.1984.
6
SV40-53K antigen: a possible role for 53K in normal cells.猿猴病毒40-53K抗原:53K在正常细胞中的可能作用。
Virology. 1981 Jul 30;112(2):785-8. doi: 10.1016/0042-6822(81)90327-5.
7
Evidence that c-myc expression defines two genetically distinct forms of colorectal adenocarcinoma.有证据表明,c-myc表达可定义两种基因上不同的结直肠癌形式。
Br J Cancer. 1985 Oct;52(4):629-32. doi: 10.1038/bjc.1985.237.
8
p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors.p53细胞肿瘤抗原:正常成人组织、胚胎及肿瘤中mRNA水平的分析
Mol Cell Biol. 1985 Oct;5(10):2851-5. doi: 10.1128/mcb.5.10.2851-2855.1985.
9
Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene.人类结肠癌中c-myc基因表达失调并非伴随着该基因的扩增或重排。
Mol Cell Biol. 1985 Aug;5(8):1969-76. doi: 10.1128/mcb.5.8.1969-1976.1985.
10
Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas.
J Pathol. 1987 Apr;151(4):285-91. doi: 10.1002/path.1711510408.